EUVIMEDEUVIMED entdecken
Crossref

A Nanozyme-Boosted MOF-CRISPR Platform for Treatment of Alzheimer’s Disease

Jie Yang, Geng Qin, Zhenqi Liu, Haochen Zhang, Xiubo Du, Jinsong Ren iD, Xiaogang Qu iD

Nano Letters · 14.08.2024 · 24 (32) · 9906-9915

DOI: 10.1021/acs.nanolett.4c02272 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nano Letters, online erschienen am 01.08.2024. Verfasst von Jie Yang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Chemical Biology and State Key Laboratory of Rare Earth Resource Utilization, Changchun Institute of Applied Chemistry, Chinese Academy…. Hauptthemen laut MEDLINE: Alzheimer Disease, Oxidative Stress. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 63 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseOxidative StressAnimalsMiceHumansNF-E2-Related Factor 2Metal-Organic FrameworksDisease Models, AnimalCRISPR-Cas SystemsCeriumBlood-Brain BarrierOxidation-ReductionAntioxidants

Stichwörter der Autor:innen

Alzheimer’s diseaseMOFamyloidnanozymeredox homeostasis

Substanzen

NF-E2-Related Factor 2Metal-Organic FrameworksCeriumceric oxideAntioxidants

Autor:innen und Institutionen

  • Laboratory of Chemical Biology and State Key Laboratory of Rare Earth Resource Utilization, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, Jilin 130022, People's Republic of China.
  • School of Applied Chemistry and Engineering, University of Science and Technology of China, Hefei, Anhui 230026, People's Republic of China.
  • College of Life Sciences and Oceanography, Shenzhen Key Laboratory of Microbial Genetic Engineering, Shenzhen University, Shenzhen 518060, People's Republic of China.

ORCID-Profile: Jinsong Ren, Xiaogang Qu

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China

Zitieren

APA

Yang, J., Qin, G., Liu, Z., Zhang, H., Du, X., Ren, J., & Qu, X. (2024). A Nanozyme-Boosted MOF-CRISPR Platform for Treatment of Alzheimer’s Disease. Nano Letters, 24(32), 9906-9915. https://doi.org/10.1021/acs.nanolett.4c02272

Vancouver

Yang J, Qin G, Liu Z, Zhang H, Du X, Ren J, et al. A Nanozyme-Boosted MOF-CRISPR Platform for Treatment of Alzheimer’s Disease. Nano Letters. 2024;24(32):9906-9915. doi:10.1021/acs.nanolett.4c02272

BibTeX
@article{Yang2024,
  author = {Yang, Jie and Qin, Geng and Liu, Zhenqi and Zhang, Haochen and Du, Xiubo and Ren, Jinsong and Qu, Xiaogang},
  title = {A Nanozyme-Boosted MOF-CRISPR Platform for Treatment of Alzheimer’s Disease},
  journal = {Nano Letters},
  year = {2024},
  volume = {24},
  number = {32},
  pages = {9906--9915},
  doi = {10.1021/acs.nanolett.4c02272}
}
Kostenlos starten →